Last Updated: November 8, 2026

CEFOTAN Drug Patent Profile

« Back to Dashboard


When do Cefotan patents expire, and what generic alternatives are available?

Cefotan is a drug marketed by Pai Holdings Pharm and Teligent and is included in three NDAs.

The generic ingredient in CEFOTAN is cefotetan disodium. There is one drug master file entry for this compound. Three suppliers are listed for this compound. Additional details are available on the cefotetan disodium profile page.

AI Deep Research
Questions you can ask:
  • What is the 5 year forecast for CEFOTAN?
  • What are the global sales for CEFOTAN?
  • What is Average Wholesale Price for CEFOTAN?
Summary for CEFOTAN
US Patents:0
Applicants:2
NDAs:3
Finished Product Suppliers / Packagers: 1
Raw Ingredient (Bulk) Api Vendors: 22
Patent Applications: 1,644
What excipients (inactive ingredients) are in CEFOTAN?CEFOTAN excipients list
DailyMed Link:CEFOTAN at DailyMed
Pharmacology for CEFOTAN

US Patents and Regulatory Information for CEFOTAN

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Pai Holdings Pharm CEFOTAN cefotetan disodium INJECTABLE;INJECTION 050588-001 Dec 27, 1985 AP RX Yes No ⤷  Start Trial ⤷  Start Trial ⤷  Start Trial
Pai Holdings Pharm CEFOTAN IN PLASTIC CONTAINER cefotetan disodium INJECTABLE;INJECTION 050694-001 Jul 30, 1993 DISCN No No ⤷  Start Trial ⤷  Start Trial ⤷  Start Trial
Teligent CEFOTAN cefotetan disodium INJECTABLE;INJECTION 063293-001 Apr 29, 1993 DISCN No No ⤷  Start Trial ⤷  Start Trial ⤷  Start Trial
Pai Holdings Pharm CEFOTAN cefotetan disodium INJECTABLE;INJECTION 050588-002 Dec 27, 1985 AP RX Yes No ⤷  Start Trial ⤷  Start Trial ⤷  Start Trial
Pai Holdings Pharm CEFOTAN cefotetan disodium INJECTABLE;INJECTION 050588-003 Apr 25, 1988 DISCN No No ⤷  Start Trial ⤷  Start Trial ⤷  Start Trial
Pai Holdings Pharm CEFOTAN IN PLASTIC CONTAINER cefotetan disodium INJECTABLE;INJECTION 050694-002 Jul 30, 1993 DISCN No No ⤷  Start Trial ⤷  Start Trial ⤷  Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.